A recent study highlighted in the Brisbane Times reveals that the shingles vaccine could temporarily increase the risk of developing mild shingles shortly after vaccination. This increase in risk is observed to last for a few weeks post-vaccination before stabilizing. Despite this temporary elevation in risk, health experts emphasize the vaccine’s overall benefits in reducing long-term shingles complications. The findings are crucial as they provide valuable insights into vaccine effects and can help healthcare providers better inform patients. The research underscores the importance of balancing short-term risks with long-term benefits, ultimately aiming to enhance patient safety and vaccine efficacy. As shingles remains a significant public health concern, understanding these short-term risks aids in making informed decisions regarding vaccination.
Brisbane TimesNew data shows 8% of Americans Were Uninsured in 2025, Potential Rise Expected Next Year
June 6, 2026
In 2025, approximately 8% of the U.S. population lacked health insurance, according to new data, raising concerns as this figure may increase in the coming